Research Topic

Quantitative proteome profiling of host-pathogen interaction

  • Submission closed.

About this Research Topic

Currently, mass spectrometry based proteomics technologies in combination with bioinformatics are being employed for identification of the all host proteins essential for infection, referred as host infectome. Hence proteomics data can provide deep insight into important aspects of the interaction between two ...

Currently, mass spectrometry based proteomics technologies in combination with bioinformatics are being employed for identification of the all host proteins essential for infection, referred as host infectome. Hence proteomics data can provide deep insight into important aspects of the interaction between two organisms and its outcome. This new type technology–driven research stands in opposition to traditional hypothesis-driven research based on previously limited information. Using this approach the protein networks involved in the cell's innate defense mechanisms can be uncovered


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Recent Articles

Loading..

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

Submission closed.

Participating Journals

Loading..

Topic Editors

Loading..

Submission Deadlines

Submission closed.

Participating Journals

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..

Comments

Loading..

Add a comment

Add comment
Back to top